Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Biocryst Pharmaceuticals Inc
Biocryst Pharmaceuticals Inc_20131212

Biocryst Pharmaceuticals Inc patents

Recent patent applications related to Biocryst Pharmaceuticals Inc. Biocryst Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Biocryst Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Biocryst Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Biocryst Pharmaceuticals Inc-related inventors

Compositions and uses of amidine derivatives

Use of a compound of formula (I): wherein A, X, Y, R1 and R2 as defined herein, in treating hereditary angioedema is disclosed. A composition containing the compounds, a polar organic solvent or a mixture thereof; and optionally a co-solvent, is also disclosed.... Biocryst Pharmaceuticals Inc

Antiviral azasugar-containing nucleosides

Disclosed are compounds comprising an azasugar attached to a heterocyclic base, including pharmaceutically acceptable salts thereof, suitable for use in inhibiting viral RNA polymerase activity or viral replication, and treating viral infections. The compounds are characterized, in part, by favorable pharmacokinetics for the active pharmaceutical ingredient, particularly in conjunction with... Biocryst Pharmaceuticals Inc

Anti-influenza compositions and methods

Disclosed are novel compounds comprising an imino-ribose derivative covalently linked to a carbocycle or heterocycle. Pharmaceutical compositions comprising the compounds of the invention are also described. Methods of inhibition, treatment and/or suppression of viral infections with the compounds of the invention are also described. The compositions or methods may optionally... Biocryst Pharmaceuticals Inc

Compositions and methods for inhibiting viral polymerase

as described herein. Compounds of Formula I are useful in methods of inhibiting viral RNA polymerase activity and viral replication. Also provided are pharmaceutical compositions comprising compounds of Formula I, as well as methods of treating viral infections using compounds of Formula I.... Biocryst Pharmaceuticals Inc

Human plasma kallikrein inhibitors

as described herein, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also disclosed are pharmaceutical compositions comprising at least one such compound, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity.... Biocryst Pharmaceuticals Inc

Methods and compositions for inhibition of polymerase

The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects. The methods comprise administering to the subject a therapeutically effective amount of a compound of... Biocryst Pharmaceuticals Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Biocryst Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Biocryst Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by